Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rinzivillo

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|July 25, 2019
Role of Combined [<sup>68</sup>Ga]Ga-DOTA-SST Analogues and [<sup>18</sup>F]FDG PET/CT in the Management of GEP-NENs: A Systematic ReviewLuciano Carideo, Daniela Prosperi, Francesco Panzuto, et al.
Pancreas|January 19, 2017
Everolimus in Pancreatic Neuroendocrine Carcinomas G3Francesco Panzuto, Maria Rinzivillo, Francesca Spada, et al.
Neuroendocrinology|October 11, 2014
The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumorsStefano Partelli, Maria Rinzivillo, Angela Maurizi, et al.
Surgical Oncology|September 3, 2020
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative managementFrancesco Panzuto, Sara Massironi, Stefano Partelli, et al.
Critical Reviews in Oncology/Hematology|November 30, 2025
Prognostic value, clinical relevance, and methodological gaps of tumor burden in neuroendocrine tumors (NETs): A systematic review of phase III randomized trials of medical therapiesGiulia Arrivi, Maria Rinzivillo, Giuseppe Badalamenti, et al.
Journal of Clinical Medicine|July 27, 2022
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual FunctionVirginia Zamponi, Anna La Salvia, Maria Grazia Tarsitano, et al.
Endocrine Oncology (Bristol, England)|February 16, 2026
Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysisGiuseppe Lamberti, Francesco Panzuto, Maria Rinzivillo, et al.
Cancers|November 27, 2024
Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative ReviewMatteo Marasco, Elena Romano, Giulia Arrivi, et al.
Neuroendocrinology|July 3, 2020
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm CellsFrancesca Terracciano, Alessia Capone, Andrea Montori, et al.
Biomedicines|February 24, 2024
Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case PresentationGiulia Arrivi, Monia Specchia, Emanuela Pilozzi, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|July 25, 2019
Role of Combined [<sup>68</sup>Ga]Ga-DOTA-SST Analogues and [<sup>18</sup>F]FDG PET/CT in the Management of GEP-NENs: A Systematic ReviewLuciano Carideo, Daniela Prosperi, Francesco Panzuto, et al.
Pancreas|January 19, 2017
Everolimus in Pancreatic Neuroendocrine Carcinomas G3Francesco Panzuto, Maria Rinzivillo, Francesca Spada, et al.
Neuroendocrinology|October 11, 2014
The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumorsStefano Partelli, Maria Rinzivillo, Angela Maurizi, et al.
Surgical Oncology|September 3, 2020
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative managementFrancesco Panzuto, Sara Massironi, Stefano Partelli, et al.
Critical Reviews in Oncology/Hematology|November 30, 2025
Prognostic value, clinical relevance, and methodological gaps of tumor burden in neuroendocrine tumors (NETs): A systematic review of phase III randomized trials of medical therapiesGiulia Arrivi, Maria Rinzivillo, Giuseppe Badalamenti, et al.
Journal of Clinical Medicine|July 27, 2022
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual FunctionVirginia Zamponi, Anna La Salvia, Maria Grazia Tarsitano, et al.
Endocrine Oncology (Bristol, England)|February 16, 2026
Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysisGiuseppe Lamberti, Francesco Panzuto, Maria Rinzivillo, et al.
Cancers|November 27, 2024
Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative ReviewMatteo Marasco, Elena Romano, Giulia Arrivi, et al.
Neuroendocrinology|July 3, 2020
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm CellsFrancesca Terracciano, Alessia Capone, Andrea Montori, et al.
Biomedicines|February 24, 2024
Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case PresentationGiulia Arrivi, Monia Specchia, Emanuela Pilozzi, et al.
Pageof 8